share_log

6-K: Report of foreign private issuer (related to financial reporting)

6-K: Report of foreign private issuer (related to financial reporting)

6-K:外國發行人報告(業績相關)
美股SEC公告 ·  09/16 19:06

牛牛AI助理已提取核心訊息

On September 11, 2024, SMX (Security Matters) Public Limited Company, a foreign private issuer, reported to the United States Securities and Exchange Commission (SEC) that it had entered into a private placement transaction with certain institutional investors. The transaction, which was facilitated by Aegis Capital Corp. as the lead placement agent and ClearThink Securities as a co-placement agent, raised aggregate gross proceeds of $5.350 million before fees and expenses. The offering included the sale of 5,350,000 Common Units, each comprising one Ordinary Share or Pre-Funded Warrant, and a combination of Series A and Series B Common Warrants. The proceeds from the private placement are intended for general corporate and working capital purposes. The transaction also involved lock-up agreements from the company...Show More
On September 11, 2024, SMX (Security Matters) Public Limited Company, a foreign private issuer, reported to the United States Securities and Exchange Commission (SEC) that it had entered into a private placement transaction with certain institutional investors. The transaction, which was facilitated by Aegis Capital Corp. as the lead placement agent and ClearThink Securities as a co-placement agent, raised aggregate gross proceeds of $5.350 million before fees and expenses. The offering included the sale of 5,350,000 Common Units, each comprising one Ordinary Share or Pre-Funded Warrant, and a combination of Series A and Series B Common Warrants. The proceeds from the private placement are intended for general corporate and working capital purposes. The transaction also involved lock-up agreements from the company's executive officers, directors, and 10% shareholders, restricting the sale of their shares for 90 days post-closing. SMX has committed to filing a registration statement with the SEC to allow for the resale of the Ordinary Shares and those underlying the Warrants and Pre-Funded Warrants. The private placement was not a public offering and was offered only to accredited investors. The company issued press releases on September 11 and September 13, 2024, regarding the pricing and closing of the transactions, respectively.
2024年9月11日,賬號使用軍方醫院訪問此特性,一個外國私募股權公司(SMX)按照美國證券交易委員會(SEC)的規定,報告了與某些機構投資者進行了一筆定向增發的交易。本次交易由Aegis Capital和ClearThink Securities作爲首席增發代理和聯席增發代理進行,總募集的毛收益爲535萬美元,不包括手續費和開支。發行包括出售535萬股普通股份,每股普通股份或Pre-Funded Warrant構成1股普通股,幷包括A類和B類普通股認股權證。定向增發所得款項將用於公司一般企業和營運資金用途。交易還涉及公司的高級管理人員、董事和10%的股東簽訂的禁售協議,限制其在閉市後的90天內出售股份。SMX承諾向 SEC 提交註冊文件,以允許普通股和認股權證和 Pre-Funded Warrant 的再銷售。本次定向增發並非公開發行,僅向合格投資者提供。公司分別在2024年9月11日和9月13日發佈了關於交易定價和交易結束的新聞稿。
2024年9月11日,賬號使用軍方醫院訪問此特性,一個外國私募股權公司(SMX)按照美國證券交易委員會(SEC)的規定,報告了與某些機構投資者進行了一筆定向增發的交易。本次交易由Aegis Capital和ClearThink Securities作爲首席增發代理和聯席增發代理進行,總募集的毛收益爲535萬美元,不包括手續費和開支。發行包括出售535萬股普通股份,每股普通股份或Pre-Funded Warrant構成1股普通股,幷包括A類和B類普通股認股權證。定向增發所得款項將用於公司一般企業和營運資金用途。交易還涉及公司的高級管理人員、董事和10%的股東簽訂的禁售協議,限制其在閉市後的90天內出售股份。SMX承諾向 SEC 提交註冊文件,以允許普通股和認股權證和 Pre-Funded Warrant 的再銷售。本次定向增發並非公開發行,僅向合格投資者提供。公司分別在2024年9月11日和9月13日發佈了關於交易定價和交易結束的新聞稿。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。